Speech-Language Pathologists in Ravenel, SC Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Jessica Sternlicht, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5540 Old Jacksonboro Rd, Ravenel, SC 29470 Phone: 843-889-9411 |
News Archive
Researchers discover potential new antimalarial treatment targets
Researchers have discovered crucial new processes that allow malaria parasites to escape red blood cells and infect other cells, offering potential new treatment targets.
New brain cells listen before they talk
Newly created neurons in adults rely on signals from distant brain regions to regulate their maturation and survival before they can communicate with existing neighboring cells - a finding that has important implications for the use of adult neural stem cells to replace brain cells lost by trauma or neurodegeneration, Yale School of Medicine researchers report in The Journal of Neuroscience.
Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device
St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.
CTC as accurate as conventional colonoscopy in detecting cancerous polyps
Computed tomographic colonography (CTC), also known as virtual colonoscopy, administered without laxatives is as accurate as conventional colonoscopy in detecting clinically significant, potentially cancerous polyps, according to a study performed jointly at the San Francisco VA Medical Center, the University of California, San Francisco and Massachusetts General Hospital.
FDA accepts Merck's SAFLUTAN NDA for standard review
Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application for SAFLUTAN, Merck's investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepted for standard review by the U.S. Food and Drug Administration.
› Verified 1 days ago